| P50 | author | Matthew D. Jose | Q37840451 |
| | Gregory M Peterson | Q39856734 |
| P2093 | author name string | R L Castelino | |
| | A Khanal | |
| P2860 | cites work | Prediction of creatinine clearance from serum creatinine | Q29615603 |
| | Medication errors in chronic kidney disease: one piece in the patient safety puzzle | Q33348175 |
| | Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size | Q33888401 |
| | Systematic comparison of four sources of drug information regarding adjustment of dose for renal function | Q33908095 |
| | Assessment of adherence to renal dosing guidelines in long-term care facilities | Q34085099 |
| | Managing older adults with CKD: individualized versus disease-based approaches | Q35680995 |
| | An analysis of discharge drug prescribing amongst elderly patients with renal impairment | Q36613151 |
| | CKD as an underrecognized threat to patient safety. | Q37009412 |
| | Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. | Q37093020 |
| | Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations | Q38035392 |
| | Management of drug therapy in the elderly | Q38662035 |
| | Considerations in the choice of interobserver reliability estimates | Q40526877 |
| | Use of drugs in patients with renal insufficiency. Workshop report | Q40647329 |
| | Dose adjustment in renal impairment: response from the British National Formulary | Q42929332 |
| | Dose adjustment in renal impairment: response from AHFS Drug Information | Q42929335 |
| | Dose adjustment in renal impairment: response from Drug Prescribing in Renal Failure | Q42929392 |
| | Evaluation of dosage adjustment in patients with renal impairment | Q44282702 |
| | Medication misuse in hospitalized patients with renal impairment | Q44557177 |
| | Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program | Q45056924 |
| | Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease | Q46522417 |
| | Implementation of the routine reporting of eGFR in Australia and New Zealand | Q46526912 |
| | A quantitative approach to drug dosing in chronic kidney disease. | Q53443090 |
| | Drug dosage adjustments according to renal function at hospital discharge. | Q53772903 |
| | Longitudinal studies on the rate of decline in renal function with age. | Q55061206 |
| P433 | issue | 1 | |
| P304 | page(s) | 77-85 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Internal Medicine Journal | Q15749165 |
| P1476 | title | Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources? | |
| P478 | volume | 44 | |